Nanotechnology and Oncology

摘要

To explore what nanomedicine is, what it can do, its potential risks and bene.ts, and the state of the art for standards and regulation, all with respect to nanomedicine in oncology, the National Cancer Policy Forum held a workshop in Washington, DC, on July 1213, 2010, titled Policy Issues in Nanotechnology and Oncology. This document is a summary of the workshop. The workshop discussions fell under several main categories: uses of nanotechnology in oncology and cancer research, research and development of new cancer nanomedicines, risk management, and nanotechnology and the public. These topics form the chapters of this summary; policy issues, such as regulation of nanotechnology-based products and the challenges of facilitating interdisciplinary education, research, and development are discussed as they arose in the workshop proceedings. The views expressed in this summary are those of the speak-ers and discussants, as attributed to them, and are not the consensus views of workshop participants of members of the National Cancer Policy Forum. Further information on nanomedicine and nanotechnology can be found by starting with reviews in the scienti.c literature (Boisselier and Astruc, 2009; Debbage, 2009; Gao et al., 2009; Kostarelos et al., 2009; Moghimi et al., 2005; Nie et al., 2007; Peer et al., 2007; Riehemann et al., 2009). This summary organizes the themes of discussion by topic, and topics and quotations are not necessarily arranged in chronological order.